EMPA-Q 10mg EMPAGLIFLOZIN – 20’S

Empa-Q Tablets, containing Empagliflozin 10mg, are primarily used for the management of type 2 diabetes mellitus. This medication works by inhibiting the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, leading to increased glucose excretion in urine and consequently lowering blood sugar levels. In addition to its glucose-lowering effects, Empa-Q has been shown to reduce the risk of cardiovascular events in patients with type 2 diabetes who have established cardiovascular disease. It is also beneficial for weight management and may help in reducing blood pressure. In Kenya, Empa-Q Tablets are gaining popularity among healthcare providers for their dual benefits in managing diabetes and improving heart health. Patients are advised to use this medication as part of a comprehensive diabetes management plan, which includes diet and exercise. Always consult a healthcare professional before starting any new medication.